ANNE EDWARDS: Open Payments
NPI 1487068540 · WINSTON-SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,343 in 124 payments from 19 companies in 2025. Trend: 2023 $2,868 · 2024 $2,654 · 2025 $2,343
Food & beverage: $2,319Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $459 |
| Galderma Laboratories, L.P. | 13 | $245 |
| Amgen Inc. | 10 | $217 |
| GENZYME CORPORATION | 8 | $212 |
| UCB, Inc. | 12 | $206 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $197 |
| Janssen Biotech, Inc. | 10 | $156 |
| Regeneron Healthcare Solutions, Inc. | 7 | $153 |
| Arcutis Biotherapeutics, Inc. | 5 | $97 |
| PFIZER INC. | 4 | $62 |
Products named: DUPIXENT, RINVOQ, OTEZLA, Bimzelx, SKYRIZI, TREMFYA, NEMLUVIO, ILUMYA.
Industry payments across NC — which companies pay providers there.
